The Fact About ABBV-744 in combination with immunotherapy That No One Is Suggesting
In Segment C, contributors will get ABBV-744 and oral navitoclax. In Phase D, individuals will get ABBV-744 and ruxolitinib. Participants will obtain treatment right until ailment progression or the individuals are unable to tolerate the study drugs.Attainable new ways for your analysis and treatment of AML. (A) The identification of Tremendous enh